Suzhou Basecare Medical Corporation Limited
HKEX:2170.HK
3 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q3 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 132.266 | 96.748 | 81.163 | 82.798 | 69.154 | 60.191 | 23.866 | 25.078 | 13.822 |
| Cost of Revenue
| 73.93 | 60.851 | 50.207 | 47.719 | 35.027 | 34.654 | 16.629 | 16.005 | 6.291 |
| Gross Profit
| 58.336 | 35.898 | 30.956 | 35.079 | 34.128 | 25.537 | 7.237 | 9.073 | 7.531 |
| Gross Profit Ratio
| 0.441 | 0.371 | 0.381 | 0.424 | 0.493 | 0.424 | 0.303 | 0.362 | 0.545 |
| Reseach & Development Expenses
| 67.038 | 70.007 | 81.387 | 53.554 | 60.641 | 26.326 | 12.514 | 8.536 | 5.501 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 20.36 | 0.008 | 0.06 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 9.592 | 2.568 | 2.434 |
| SG&A
| 144.53 | 85.408 | 112.496 | 73.947 | 70.252 | 55.539 | 29.952 | 2.576 | 2.494 |
| Other Expenses
| 0 | -0.187 | 0 | 0 | 0 | 0 | 0.072 | 0.003 | 0.554 |
| Operating Expenses
| 211.568 | 155.602 | 193.883 | 127.501 | 130.893 | 81.865 | 36.064 | 24.262 | 8.966 |
| Operating Income
| -153.232 | -119.705 | -162.928 | -92.422 | -96.766 | -56.328 | -28.475 | -15.247 | -0.622 |
| Operating Income Ratio
| -1.159 | -1.237 | -2.007 | -1.116 | -1.399 | -0.936 | -1.193 | -0.608 | -0.045 |
| Total Other Income Expenses Net
| 4.077 | 53.82 | 56.804 | 53.737 | -10.184 | 11.472 | -0.319 | -24.93 | -158.296 |
| Income Before Tax
| -149.154 | -65.885 | -106.124 | -38.684 | -106.949 | -44.856 | -28.794 | -40.177 | -158.918 |
| Income Before Tax Ratio
| -1.128 | -0.681 | -1.308 | -0.467 | -1.547 | -0.745 | -1.206 | -1.602 | -11.497 |
| Income Tax Expense
| -7.786 | 4.792 | 5.047 | 1.829 | 16.486 | 5.653 | -3.126 | -1.962 | 0.278 |
| Net Income
| -140.785 | -69.405 | -110.629 | -40.079 | -123.435 | -50.508 | -25.668 | -44.18 | -160.274 |
| Net Income Ratio
| -1.064 | -0.717 | -1.363 | -0.484 | -1.785 | -0.839 | -1.076 | -1.762 | -11.596 |
| EPS
| -0.51 | -0.25 | -0.4 | -0.15 | -0.45 | -0.18 | 0 | 0 | 0 |
| EPS Diluted
| -0.51 | -0.25 | -0.4 | -0.15 | -0.45 | -0.18 | 0 | 0 | 0 |
| EBITDA
| -138.307 | -113.199 | -158.649 | -87.968 | -93.397 | -52.965 | -27.293 | -42.662 | -173.954 |
| EBITDA Ratio
| -1.046 | -1.17 | -1.955 | -1.062 | -1.351 | -0.88 | -1.144 | -0.602 | 0.102 |